Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: shandong

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: T/T

    Aliase: 184475-35-2
    Purity: 99%
    Appearance:white powder
    Usage: Gefitinib is an antineoplastic target therapy drug with relatively high specificity that was developed by the British
    pharmaceutical company AstraZeneca, it is the first molecular targeted drug to be used in non-small cell lung cancer treatment.
    Epidermal growth factors (EGF) are a kind of polypeptide with a relative molecular mass of 6.45x103, and they can bind with
    epidermal growth factor receptors (EGFR) on target cell membrane surfaces to trigger biological effects. EGFR is a type of tyrosine kinase (TK) type receptor, so when bound with EGF, it will promote TK activation in the receptor. This will cause tyrosine residue in the receptor to autophosphorylate and send continuous dividing signals into the cell, causing cell proliferation and differentiation.EGFR is abundant in human tissue, and it is highly expressed in malign tumors. Geftinib blocks the signal transduction pathway of
    cell surface EGFR to prevent tumor growth, metastasis, and growth in blood vessels, and it can induce tumor cell apoptosis. Gefitinib is mainly used to treat non-stem cell lung cancer.

Send your message to this supplier
  • From:
  • To:
    Jinan Jianfeng Chemical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service